Abstract
Osteomyelitis is often challenging to treat. This analysis examined the clinical experience of patients with gram-positive osteomyelitis treated with ceftaroline fosamil in the phase 4 Clinical Assessment Program and Teflaro® Utilization Registry (CAPTURE) study. Data including patient demographics, past illnesses, risk factors, disease characteristics, antibiotic use, pathogens isolated, and clinical outcome were collected between September 2013 and February 2015 by review of randomly ordered patient charts from participating sites in the United States. Clinical success was defined as discontinuation of ceftaroline fosamil following clinical cure with no further need for antibiotics or clinical improvement with switch to another antibiotic treatment. A total of 150 patients with gram-positive osteomyelitis were treated with ceftaroline fosamil. Most patients (117/150; 78.0%) were treated with 600 mg ceftaroline fosamil per dose; 143/150 patients (95.3%) received a dose every 12 h. The majority (89/150 patients; 59.3%) had been previously diagnosed with diabetes mellitus or peripheral arterial disease. Osteomyelitis was associated with hardware in 32/150 patients (21.3%). Methicillin-resistant and methicillin-susceptible Staphy...Continue Reading
References
Apr 15, 2000·Journal of Diabetes and Its Complications·M EnerothJ Apelqvist
Jul 25, 2000·Postgraduate Medical Journal·J Ciampolini, K G Harding
Apr 2, 2003·The Journal of Antimicrobial Chemotherapy·Alan D TiceDavid A Shoultz
Dec 18, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin A LipskyUNKNOWN Linezolid Diabetic Foot Infections Study Group
Jul 28, 2004·Lancet·Daniel P Lew, Francis A Waldvogel
Jul 16, 2008·Antimicrobial Agents and Chemotherapy·Yigong GeDaniel F Sahm
Mar 3, 2010·Antimicrobial Agents and Chemotherapy·K Kosowska-ShickP C Appelbaum
Aug 11, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G Ralph CoreyDirk Thye
Nov 12, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas M FileDirk Thye
Dec 9, 2010·The Journal of Antimicrobial Chemotherapy·G Ralph CoreyUNKNOWN CANVAS 1 investigators
Dec 9, 2010·The Journal of Antimicrobial Chemotherapy·Mark H WilcoxUNKNOWN CANVAS 2 investigators
Dec 14, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad Spellberg, Benjamin A Lipsky
Apr 18, 2013·Journal of Clinical Pharmacy and Therapeutics·R H RimawiP P Cook
Feb 20, 2014·Antimicrobial Agents and Chemotherapy·Anthony M CasapaoMichael J Rybak
May 9, 2014·Pharmacotherapy·Rupali JainPaul S Pottinger
Aug 26, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Felix K Yam, Brian K Kwan
Nov 25, 2014·Diabetes/metabolism Research and Reviews·B A LipskyE J C Goldstein
Jan 13, 2015·Infectious Diseases in Clinical Practice : IDCP·Jose A VazquezH David Friedland
Apr 22, 2015·Antimicrobial Agents and Chemotherapy·Julie Ann JustoKeith A Rodvold
May 23, 2015·The Journal of Bone and Joint Surgery. American Volume·Hilal Maradit KremersPaul M Huddleston
Citations
Oct 29, 2019·Expert Opinion on Emerging Drugs·Adamantia LiapikouToni Torres
Aug 28, 2020·SAGE Open Medical Case Reports·Shafee Salloum
Mar 23, 2019·Antibiotics·Nicole LounsburyChristiane Chbib
Oct 9, 2019·Expert Opinion on Emerging Drugs·Matteo BassettiMark Wilcox
Jan 19, 2021·The Journal of Hand Surgery, European Volume·Matthew WymanVictoria Giblin
May 1, 2021·Journal of Clinical Medicine·Annemieke BloemNelianne J Verkaik
Aug 12, 2021·EFORT Open Reviews·Tamer El-Sobky, Shady Mahmoud